<qa>  What is the purpose of this study?The purpose of this study is to determine the safety and preliminary effectiveness of ixabepilone plus lapatinib with and without capecitabine in the treatment of human epidermal growth factor receptor 2 HER2-positive or metastatic breast cancer. 